- Home
- MFP vs PBH Comparison
MFP vs PBH Comparison
Compare MFP & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MFP | PBH |
|---|---|---|
| Founded | N/A | 1996 |
| Country | United States | United States |
| Employees | N/A | 890 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.2B |
| IPO Year | 2025 | 2004 |
Fundamental Metrics
Financial Performance| Metric | MFP | PBH |
|---|---|---|
| Price | $44.84 | $47.60 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $75.33 |
| AVG Volume (30 Days) | 415.4K | ★ 438.1K |
| Earning Date | N/A | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $975,777,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.31 |
| P/E Ratio | ★ N/A | $78.25 |
| Revenue Growth | N/A | ★ 36.77 |
| 52 Week Low | $40.00 | $42.62 |
| 52 Week High | $52.58 | $71.07 |
Technical Indicators
Market Signals| Indicator | MFP | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 49.51 | 42.11 |
| Support Level | $40.92 | $44.86 |
| Resistance Level | $49.11 | $49.79 |
| Average True Range (ATR) | 2.19 | 1.50 |
| MACD | 0.13 | -0.21 |
| Stochastic Oscillator | 68.68 | 28.66 |
Price Performance
Historical ComparisonAbout PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.